In summary, our data have demonstrated forced deficiency of PDHA1 expression by KO in prostate cancer cells results in metabolic reprogramming towards higher glutaminolysis, a process being preferentially vulnerable to glutamine inhibitors. The gene discussed is PDHA1; the disease is prostate cancer.